Genetic testing for Alzheimer's and long-term care insurance.

Journal Article (Journal Article)

A genetic marker known as apolipoprotein E provides a clear signal of a person's risk of developing Alzheimer's disease and thus that person's future need for long-term care. People who find that they have the variant of the trait that increases Alzheimer's disease risk are more likely to purchase long-term care insurance after receiving this information. If the information is widely introduced into the insurance market, coverage rates could be affected in different ways, depending on who possesses that information. Policymakers will eventually need to confront the issue of the use of this and other markers in the pricing of long-term care insurance.

Full Text

Duke Authors

Cited Authors

  • Taylor, DH; Cook-Deegan, RM; Hiraki, S; Roberts, JS; Blazer, DG; Green, RC

Published Date

  • 2010

Published In

Volume / Issue

  • 29 / 1

Start / End Page

  • 102 - 108

PubMed ID

  • 20048367

Pubmed Central ID

  • PMC2931337

Electronic International Standard Serial Number (EISSN)

  • 1544-5208

Digital Object Identifier (DOI)

  • 10.1377/hlthaff.2009.0525

Language

  • eng

Conference Location

  • United States